Online Purchasing Account You are logged on as Guest. LoginRegister a New AccountShopping cart (Empty)
United States 

ETB receptor antagonist [RES-701-1]

ALX-155-018-MC05 0.5 mg 108.00 USD
Do you need bulk/larger quantities?
Inhibits selectively the ET-1 binding to the ETB receptor.

Product Specification

(Beta peptide bond between Gly1and Asp9).
Peptide Content:75-90%
Purity:≥97% (HPLC)
Solubility:Soluble in DMSO (5mg/ml); dilute with 0.6ml distilled water.
Long Term Storage:-20°C
Regulatory Status:RUO - Research Use Only

Product Literature References

J.X. He, et al.; Bioorg. Med. Chem. Lett. 5, 621 (1995),
RES-701-1, a novel and selective endothelin type B receptor antagonist produced by Streptomyces sp. RE-701. I. Characterization of producing strain, fermentation, isolation, physico-chemical and biological properties: Y. Morishita, et al.; J. Antibiot. 47, 269 (1994), Abstract;
Subtypes of endothelin ETA and ETB receptors mediating venous smooth muscle contraction: S.A. Sudjarwo, et al.; BBRC 200, 627 (1994), Abstract;

Recommend this page

Keep in touch

©2020 Enzo Life Sciences, Inc.,